FDANonrulemakingFDA-2023-D-3133

Who commented on this docket

Recommendations for the Use of Clinical Data in Premarket Notification [510(k)] Submissions; Draft Guidance for Industry and Food and Drug Administration Staff; Availability

2 organizations filed 2 public comments on Recommendations for the Use of Clinical Data in Premarket Notification [510(k)] Submissions; Draft Guidance for Industry and Food and Drug Administration Staff; Availability, at the Food and Drug Administration. The comment window closed 965d ago.

Organizations
2
Comments
2
RIN
Comment window
closed 965d ago

Abstract

OPEN

Commenters (2)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.